Clonazepam Tablets Recalled Due to Incorrect Carton Labeling
Endo USA recalls clonazepam tablets because some cartons are labeled with incorrect declared strength. The medication inside the blister strips contains the correct strength.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I designation establishes a minimum severity score of 4 per the classification rules. Although no illnesses or injuries have been reported, the labeling discrepancy on a controlled benzodiazepine carton justifies this severity level.
Plain-English summary
Endo USA, Inc. is recalling Clonazepam Orally Disintegrating Tablets USP 0.25 mg because some product cartons are labeled with incorrect declared strength. However, the blister strips inside the product carton reflect the correct strength.
The recall affects 72,973 cartons distributed nationwide. The affected cartons are from lots 550142801, 550142901, 550143001, 550143101, 550143201, 550143301, 550143401, 550147201, and 550147401, with an expiration date of August 31, 2026. The product is distributed by PAR Pharmaceutical, Chestnut Ridge, New York.
The recalled product
- Product
- CLONAZEPAM (CLONAZEPAM)
- Brand
- CLONAZEPAM
- Manufacturer
- Endo USA, Inc.
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot #s: 550142801
- 550142901
- 550143001
- 550143101
- 550143201
- 550143301
- 550143401
- 550147201
- 550147401
- Exp. 08/31/2026.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CLONAZEPAM
- CriticalClonazepam Orally Disintegrating Tablets Carton Mislabeled on Declared Strength
FDA (Drugs) · 2025-01-15
- SevereClonazepam Tablets Recalled Due to Carton Labeling Error
FDA (Drugs) · 2025-01-15
- SevereClonazepam tablets recalled for incorrect carton labeling
FDA (Drugs) · 2025-01-15
- SevereClonazepam Tablets Recalled Due to Carton Labeling Error
FDA (Drugs) · 2024-08-07
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27